{"data":[{"accessionNo":"0002012383-26-003736","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001253689","issuerName":"CRESCENT BIOPHARMA INC","ticker":"CBIO","cusip":"G2545C104","securityClass":"Common Stock","eventDate":"2026-09-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":2075291,"percentOfClass":5.6,"filedAt":"2026-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001172661-26-003420","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":"38000Q201","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BAM GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":1662917,"percentOfClass":6.03,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001172661-26-003420","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":"38000Q201","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BALYASNY ASSET MANAGEMENT L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":1662917,"percentOfClass":6.03,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001172661-26-003420","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":"38000Q201","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Dames GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":1662917,"percentOfClass":6.03,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001172661-26-003420","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":"38000Q201","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Dmitry Balyasny","reportingCik":null,"personType":"HC,IN","sharesOwned":1662917,"percentOfClass":6.03,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001172661-26-003420","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":"38000Q201","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Balyasny Asset Management Holdings LP","reportingCik":null,"personType":"HC,PN","sharesOwned":1662917,"percentOfClass":6.03,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001104659-26-085114","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":"G2545C104","securityClass":"Ordinary Shares, $0.001 par value","eventDate":"2026-07-16","reportingPerson":"Peter Harwin","reportingCik":"0001663607","personType":"IN","sharesOwned":6602408,"percentOfClass":16.52,"filedAt":"2026-07-20","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001104659-26-085114","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":"G2545C104","securityClass":"Ordinary Shares, $0.001 par value","eventDate":"2026-07-16","reportingPerson":"Fairmount Healthcare Fund II L.P.","reportingCik":"0001769651","personType":"PN","sharesOwned":6593385,"percentOfClass":16.5,"filedAt":"2026-07-20","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001104659-26-085114","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":"G2545C104","securityClass":"Ordinary Shares, $0.001 par value","eventDate":"2026-07-16","reportingPerson":"Fairmount Funds Management LLC","reportingCik":"0001802528","personType":"IA","sharesOwned":6593385,"percentOfClass":16.5,"filedAt":"2026-07-20","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001104659-26-085114","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":"G2545C104","securityClass":"Ordinary Shares, $0.001 par value","eventDate":"2026-07-16","reportingPerson":"Tomas Kiselak","reportingCik":"0001830177","personType":"IN","sharesOwned":6593385,"percentOfClass":16.5,"filedAt":"2026-07-20","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001193125-26-225181","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":"38000Q201","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Balyasny Asset Management L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":1510033,"percentOfClass":5.48,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001193125-26-225181","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":"38000Q201","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"BAM GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":1510033,"percentOfClass":5.48,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001193125-26-225181","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":"38000Q201","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Balyasny Asset Management Holdings LP","reportingCik":null,"personType":"HC,PN","sharesOwned":1510033,"percentOfClass":5.48,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001193125-26-225181","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":"38000Q201","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Dames GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":1510033,"percentOfClass":5.48,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001193125-26-225181","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":"38000Q201","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Dmitry Balyasny","reportingCik":null,"personType":"HC,IN","sharesOwned":1510033,"percentOfClass":5.48,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001214659-26-006496","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":"G2545C104","securityClass":"Ordinary Shares, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"KEVIN TANG","reportingCik":null,"personType":"IN","sharesOwned":1160000,"percentOfClass":4.21,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001214659-26-006496","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":"G2545C104","securityClass":"Ordinary Shares, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"TANG CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"OO","sharesOwned":1160000,"percentOfClass":4.21,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001214659-26-006496","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":"G2545C104","securityClass":"Ordinary Shares, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"TANG CAPITAL PARTNERS, LP","reportingCik":null,"personType":"PN","sharesOwned":616477,"percentOfClass":2.24,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001214659-26-006496","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":"G2545C104","securityClass":"Ordinary Shares, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"TANG CAPITAL PARTNERS INTERNATIONAL, LP","reportingCik":null,"personType":"PN","sharesOwned":451619,"percentOfClass":1.64,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001214659-26-006496","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":"G2545C104","securityClass":"Ordinary Shares, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"TANG CAPITAL PARTNERS III, INC","reportingCik":null,"personType":"CO","sharesOwned":91904,"percentOfClass":0.33,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001214659-26-006496","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":"G2545C104","securityClass":"Ordinary Shares, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"TANG CAPITAL PARTNERS IV, INC","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001738048-26-000018","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":null,"securityClass":"Ordinary Shares, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"VHCP Co-Investment Holdings III, LLC","reportingCik":null,"personType":"OO","sharesOwned":2666064,"percentOfClass":9.5,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001738048-26-000018","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":null,"securityClass":"Ordinary Shares, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"VHCP Management III, LLC","reportingCik":null,"personType":"OO","sharesOwned":2666064,"percentOfClass":9.5,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001738048-26-000018","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":null,"securityClass":"Ordinary Shares, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"VHCP Management EG, LLC","reportingCik":null,"personType":"OO","sharesOwned":2666064,"percentOfClass":9.5,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001738048-26-000018","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":null,"securityClass":"Ordinary Shares, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"Nimish Shah","reportingCik":null,"personType":"IN","sharesOwned":2666064,"percentOfClass":9.5,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001738048-26-000018","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":null,"securityClass":"Ordinary Shares, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"Bong Y. Koh","reportingCik":null,"personType":"IN","sharesOwned":2666064,"percentOfClass":9.5,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001738048-26-000018","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":null,"securityClass":"Ordinary Shares, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"Venrock Healthcare Capital Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2666064,"percentOfClass":9.5,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001738048-26-000018","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":null,"securityClass":"Ordinary Shares, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"Venrock Healthcare Capital Partners EG, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2666064,"percentOfClass":9.5,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0000902664-26-001077","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001253689","issuerName":"CRESCENT BIOPHARMA, INC.","ticker":"CBIO","cusip":null,"securityClass":"Ordinary Shares, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Ryan Wilder","reportingCik":null,"personType":"HC,IN","sharesOwned":1500000,"percentOfClass":5.4,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0000902664-26-001077","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001253689","issuerName":"CRESCENT BIOPHARMA, INC.","ticker":"CBIO","cusip":null,"securityClass":"Ordinary Shares, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Vestal Point Capital, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":1500000,"percentOfClass":5.4,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0000315066-26-000413","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"CRESCENT BIOPHARMA INC","ticker":"CBIO","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":4133514,"percentOfClass":15,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0000315066-26-000413","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"CRESCENT BIOPHARMA INC","ticker":"CBIO","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":4133514,"percentOfClass":15,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001193125-25-315863","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":null,"securityClass":"Ordinary Shares, $0.001 par value per share","eventDate":"2025-12-08","reportingPerson":"ForGrowth III PA B.V.","reportingCik":null,"personType":"OO","sharesOwned":1677852,"percentOfClass":6.1,"filedAt":"2025-12-11","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001193125-25-315863","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":null,"securityClass":"Ordinary Shares, $0.001 par value per share","eventDate":"2025-12-08","reportingPerson":"Forbion Growth Opportunities Fund III Cooperatief U.A.","reportingCik":null,"personType":"OO","sharesOwned":1677852,"percentOfClass":6.1,"filedAt":"2025-12-11","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001193125-25-315863","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":null,"securityClass":"Ordinary Shares, $0.001 par value per share","eventDate":"2025-12-08","reportingPerson":"Forbion Growth III Management B.V.","reportingCik":null,"personType":"OO","sharesOwned":1677852,"percentOfClass":6.1,"filedAt":"2025-12-11","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001104659-25-119323","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":null,"securityClass":"Ordinary Shares, $0.001 par value","eventDate":"2025-12-04","reportingPerson":"Fairmount Funds Management LLC","reportingCik":"0001802528","personType":"IA","sharesOwned":5643482,"percentOfClass":18.53,"filedAt":"2025-12-08","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001104659-25-119323","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":null,"securityClass":"Ordinary Shares, $0.001 par value","eventDate":"2025-12-04","reportingPerson":"Fairmount Healthcare Fund II L.P.","reportingCik":"0001769651","personType":"PN","sharesOwned":5643482,"percentOfClass":18.53,"filedAt":"2025-12-08","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001104659-25-119323","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":null,"securityClass":"Ordinary Shares, $0.001 par value","eventDate":"2025-12-04","reportingPerson":"Peter Evan Harwin","reportingCik":"0001663607","personType":"IN","sharesOwned":5643482,"percentOfClass":18.53,"filedAt":"2025-12-08","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001104659-25-119323","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":null,"securityClass":"Ordinary Shares, $0.001 par value","eventDate":"2025-12-04","reportingPerson":"Tomas Kiselak","reportingCik":"0001830177","personType":"IN","sharesOwned":5643482,"percentOfClass":18.53,"filedAt":"2025-12-08","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001214659-25-014932","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":null,"securityClass":"Ordinary Shares, par value $0.001 per share","eventDate":"2025-10-07","reportingPerson":"1Globe Capital LLC","reportingCik":null,"personType":"OO","sharesOwned":1425432,"percentOfClass":10.3,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001214659-25-014932","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":null,"securityClass":"Ordinary Shares, par value $0.001 per share","eventDate":"2025-10-07","reportingPerson":"Jiaqiang Li","reportingCik":null,"personType":"IN","sharesOwned":1425432,"percentOfClass":10.3,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001214659-25-014813","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":null,"securityClass":"Ordinary Shares, $0.001 par value per share","eventDate":"2025-10-02","reportingPerson":"TANG CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"OO","sharesOwned":700000,"percentOfClass":5.04,"filedAt":"2025-10-09","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001214659-25-014813","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":null,"securityClass":"Ordinary Shares, $0.001 par value per share","eventDate":"2025-10-02","reportingPerson":"KEVIN TANG","reportingCik":null,"personType":"IN","sharesOwned":700000,"percentOfClass":5.04,"filedAt":"2025-10-09","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001214659-25-014813","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":null,"securityClass":"Ordinary Shares, $0.001 par value per share","eventDate":"2025-10-02","reportingPerson":"TANG CAPITAL PARTNERS, LP","reportingCik":null,"personType":"PN","sharesOwned":393681,"percentOfClass":2.84,"filedAt":"2025-10-09","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001214659-25-014813","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":null,"securityClass":"Ordinary Shares, $0.001 par value per share","eventDate":"2025-10-02","reportingPerson":"TANG CAPITAL PARTNERS INTERNATIONAL, LP","reportingCik":null,"personType":"PN","sharesOwned":306319,"percentOfClass":2.2,"filedAt":"2025-10-09","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001214659-25-014813","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":null,"securityClass":"Ordinary Shares, $0.001 par value per share","eventDate":"2025-10-02","reportingPerson":"TANG CAPITAL PARTNERS III, INC","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-10-09","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"},{"accessionNo":"0001214659-25-014813","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001253689","issuerName":"Crescent Biopharma, Inc.","ticker":"CBIO","cusip":null,"securityClass":"Ordinary Shares, $0.001 par value per share","eventDate":"2025-10-02","reportingPerson":"TANG CAPITAL PARTNERS IV, INC","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-10-09","canonicalUrl":"https://xoomar.com/markets/stocks/cbio"}],"updatedAt":"2026-11-05T11:48:37.109Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/cbio","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}